By elaborately constructing a Fe–Zn based diatomic catalyst, the active center is changed from FeN 4– ZnN 4 to FeN 4– Zn–N 2 after protonation, leading to the well-maintained FeN 4 structure and thus high stability of ORR.
No takes yet. Share an insight, caveat, or question.
Li et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: